1978
DOI: 10.1093/ajcn/31.10.1793
|View full text |Cite
|
Sign up to set email alerts
|

Therapy with essential amino acids and their nitrogen-free analogues in severe renal failure

Abstract: The effects of therapy with essential amino acids and their nitrogen-free hydroxy and keto precursers on nitrogen and amino acid metabolism of patients with chronic renal failure were examined. Data obtained under treatment with essential amino acids and alpha-keto acid analogues showed higher levels of plasma amino acids, C3-complement, and transferrin than with a low-protein diet alone. Nitrogen balance became positive and plasma urea levels fell. With keto acid analogue therapy, these effects could be obtai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1978
1978
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…[23][24][25] The use of KA analogues to form EAAs has been shown particularly well in studies in which KA analogues were used as supplements to VLPDs or amino acid diets for patients with CKD, and neutral or positive nitrogen balance was maintained. 24,[26][27][28][29][30] The anticatabolic or anabolic actions of KA/EAA supplements are still incompletely understood. KA/ EAA supplements commonly contain substantial amounts of 4-methyl-2-oxovaleric acid, the KA analogue of leucine (ketoleucine), 31 which may suppress protein degradation.…”
Section: Nutritional Value Of Ka Analoguesmentioning
confidence: 99%
See 1 more Smart Citation
“…[23][24][25] The use of KA analogues to form EAAs has been shown particularly well in studies in which KA analogues were used as supplements to VLPDs or amino acid diets for patients with CKD, and neutral or positive nitrogen balance was maintained. 24,[26][27][28][29][30] The anticatabolic or anabolic actions of KA/EAA supplements are still incompletely understood. KA/ EAA supplements commonly contain substantial amounts of 4-methyl-2-oxovaleric acid, the KA analogue of leucine (ketoleucine), 31 which may suppress protein degradation.…”
Section: Nutritional Value Of Ka Analoguesmentioning
confidence: 99%
“…90 The few studies that directly compared KA/EAA-and EAA-supplemented VLPDs usually evaluated small numbers of patients and suggested either no differences or possibly modest advantages to the KA/EAA-supplemented VLPD in terms of lower serum urea, phosphorus, and possibly triglyceride levels. 8,28,41,92,93 Two randomized studies indicated slower GFR loss with the KA/EAA-versus EAA-supplemented VLPD. 46,94 …”
Section: Ka/eaa-versus Eaa-supplemented Vlpdsmentioning
confidence: 99%
“…A single study in uremic subjects, re ported in preliminary form, reached the same conclusions [60].…”
Section: Selection Of Analogue Mixtures For Use In Chronic Renal Failurementioning
confidence: 55%
“…Conditions largely associated with aging have been a frequent target of EAA therapy, including sarcopenia [ 62 , 85 ], long-term-care-acquired infections [ 86 ], low physical function [ 63 ], and heart failure [ 40 , 87 , 88 ]. Beneficial effects of EAAs have also been reported in the following conditions or situations: rehabilitation [ 89–92 ]; stroke [ 93 , 94 ]; bed rest/immobilization [ 8 , 65 , 95–97 ]; peripheral artery disease [ 98 ]; renal failure [ 99–103 ]; inflammation [ 104 , 105 ]; critical illness [ 106 ]; lung cancer [ 107 ]; cystic fibrosis [ 108 ]; chronic obstructive pulmonary disease [ 109–111 ]; wound healing [ 112 ]; brain injury [ 113 , 114 ]; metabolic syndrome and cardiovascular risk factors [ 115–117 ]; obesity [ 118 , 119 ]; liver fat [ 115 , 120–122 ]; and diabetes [ 123–127 ]. Importantly, in all of these studies beneficial effects were observed despite the absence of control of the consumption of EAAs contained in dietary protein, implying the importance of the rapid and complete absorption of free EAAs in clinical circumstances in which digestion may be impaired and anabolic resistance is prevalent.…”
Section: Eaas and Clinical Conditions And Outcomesmentioning
confidence: 99%